GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Total Assets

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Total Assets : $143.78 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings Total Assets?

Integrated Diagnostics Holdings's Total Assets for the quarter that ended in Mar. 2024 was $143.78 Mil.

During the past 12 months, Integrated Diagnostics Holdings's average Total Assets Growth Rate was -32.90% per year. During the past 3 years, the average Total Assets Growth Rate was -8.90% per year. During the past 5 years, the average Total Assets Growth Rate was 0.20% per year. During the past 10 years, the average Total Assets Growth Rate was -3.10% per year.

During the past 12 years, Integrated Diagnostics Holdings's highest 3-Year average Total Assets Growth Rate was 16.80%. The lowest was -25.00%. And the median was -6.90%.

Total Assets is connected with ROA %. Integrated Diagnostics Holdings's annualized ROA % for the quarter that ended in Mar. 2024 was 22.40%. Total Assets is also linked to Revenue through Asset Turnover. Integrated Diagnostics Holdings's Asset Turnover for the quarter that ended in Mar. 2024 was 0.16.


Integrated Diagnostics Holdings Total Assets Historical Data

The historical data trend for Integrated Diagnostics Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Total Assets Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 233.55 266.17 396.95 214.98 186.68

Integrated Diagnostics Holdings Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 214.98 180.79 177.08 186.68 143.78

Integrated Diagnostics Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Integrated Diagnostics Holdings's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=100.313+86.362
=186.68

Integrated Diagnostics Holdings's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=75.642+68.142
=143.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integrated Diagnostics Holdings  (OTCPK:IDGXF) Total Assets Explanation

Total Assets is connected with ROA %.

Integrated Diagnostics Holdings's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=37.016/( (186.675+143.783)/ 2 )
=37.016/165.229
=22.40 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Integrated Diagnostics Holdings's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=25.942/( (186.675+143.783)/ 2 )
=25.942/165.229
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Integrated Diagnostics Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
12 Castle Street, Saint Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN 09-24-2021